Gillanders Arbuthnot Intrinsic Value
Gillanders Arbuthnot (GILLANDERS) median intrinsic value is ₹181.70 from 4 valuation models (range ₹36–₹227), vs current price ₹90.85 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. Browse GILLANDERS financial statements for revenue, profit, balance sheet and cash flow data.
GILLANDERS Valuation Methods Summary — DCF, Graham Number & P/E
Gillanders Arbuthnot intrinsic value across 4 models vs current price ₹90.85 — upside/downside and value range per method. For current market price and key ratios, visit GILLANDERS share price.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹227.12 | ₹204.41 - ₹249.83 | +150.0% | Book Value/Share: ₹122.86, P/B: 2.5x |
| Revenue Multiple Method | revenue | ₹181.70 | ₹163.53 - ₹199.87 | +100.0% | Revenue/Share: ₹207.62, P/S: 1.5x |
| EBITDA Multiple Method | earnings | ₹36.34 | ₹32.71 - ₹39.97 | -60.0% | EBITDA: ₹4.00Cr, EV/EBITDA: 12x |
| Simple DCF (5Y) | dcf | ₹36.34 | ₹29.07 - ₹43.61 | -60.0% | CF Growth: 5.0%, Discount: 15% |
GILLANDERS Intrinsic Value vs Market Price — All Valuation Models
Gillanders Arbuthnot fair value range ₹36–₹227 vs current market price ₹90.85 across 4 valuation models. Also explore GILLANDERS price movement history to track price trends across different timeframes.
GILLANDERS Intrinsic Value Analysis — Undervalued or Overvalued?
Gillanders Arbuthnot median intrinsic value ₹181.70, current price ₹90.85 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of GILLANDERS?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Gillanders Arbuthnot (GILLANDERS) is ₹181.70 (median value). With the current market price of ₹90.85, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹36.34 to ₹227.12, indicating ₹36.34 - ₹227.12.
Is GILLANDERS undervalued or overvalued?
Based on our multi-method analysis, Gillanders Arbuthnot (GILLANDERS) appears to be trading below calculated value by approximately 100.0%.
GILLANDERS Financial Health — Key Ratios vs Industry Benchmarks
Gillanders Arbuthnot financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 4.29 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -6.2% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -4.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.79x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
GILLANDERS Cash Flow Quality — Operating & Free Cash Flow
Gillanders Arbuthnot operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹8 Cr | ₹5 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹33 Cr | ₹32 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹48 Cr | ₹48 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹69 Cr | ₹68 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹68 Cr | ₹68 Cr | Positive Free Cash Flow | 8/10 |